MediciNova (MNOV) delivered earnings and revenue surprises of 0.00% and -7.63%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
MediciNova (MNOV) delivered earnings and revenue surprises of 0.00% and -7.63%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Gyre Therapeutics, Inc. (GYRE) delivered earnings and revenue surprises of +126.67% and +15.15%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
MediciNova (MNOV) delivered earnings and revenue surprises of +16.67% and +205.63%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
MaxCyte (MXCT) delivered earnings and revenue surprises of +33.33% and +11.86%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Alector (ALEC) delivered earnings and revenue surprises of +12.50% and +283.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
MediciNova (NASDAQ:MNOV) will be releasing earnings after the market closes on Wednesday, May 13. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-13-medicinova-inc-stock...
MediciNova, Inc. (NASDAQ:MNOV - Get Free Report) saw a large decline in short interest in April. As of April 15th, there was short interest totaling 168,023 shares, a decline of 16.4% from the March...
Shares of MediciNova, Inc. (NASDAQ:MNOV - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the seven ratings firms that are currently covering the firm...